Vallée Alexandre
Department of Epidemiology-Data-Biostatistics, Delegation of Clinical Research and Innovation (DRCI), Foch Hospital, 92150 Suresnes, France.
J Clin Med. 2022 Apr 29;11(9):2512. doi: 10.3390/jcm11092512.
Background: Arterial stiffness (AS), measured by arterial stiffness index (ASI), can be considered as a major denominator in cardiovascular (CV) diseases. Thus, it remains essential to highlight the risk factors influencing its increase among healthy participants. Methods: According to European consensus, AS is defined as ASI > 10 m/s. The purpose of this study was to investigate the determinants of the arterial stiffness (ASI > 10 m/s) among UK Biobank normotensive and healthy participants without comorbidities and previous CV diseases. Thus, a cross-sectional study was conducted on 22,452 healthy participants. Results: Participants were divided into two groups, i.e., ASI > 10 m/s (n = 5782, 25.8%) and ASI < 10 m/s (n = 16,670, 74.2%). All the significant univariate covariables were included in the multivariate analysis. The remaining independent factors associated with AS were age (OR = 1.063, threshold = 53.0 years, p < 0.001), BMI (OR = 1.0450, threshold = 24.9 kg/m2, p < 0.001), cystatin c (OR = 1.384, threshold = 0.85 mg/L, p = 0.011), phosphate (OR = 2.225, threshold = 1.21 mmol/L, p < 0.001), triglycerides (OR = 1.281, threshold = 1.09 mmol/L, p < 0.001), mean BP (OR = 1.028, threshold = 91.2 mmHg, p < 0.001), HR (OR = 1.007, threshold = 55 bpm, p < 0.001), Alkaline phosphate (OR = 1.002, threshold = 67.9 U/L, p = 0.004), albumin (OR = 0.973, threshold = 46.0 g/L, p < 0.001), gender (male, OR = 1.657, p < 0.001) and tobacco use (current, OR = 1.871, p < 0.001). Conclusion: AS is associated with multiple parameters which should be investigated in future prospective studies. Determining the markers of increased ASI among healthy participants participates in the management of future CV risk for preventive strategies.
通过动脉僵硬度指数(ASI)测量的动脉僵硬(AS)可被视为心血管(CV)疾病的一个主要因素。因此,强调健康参与者中影响其升高的风险因素仍然至关重要。方法:根据欧洲共识,AS被定义为ASI>10米/秒。本研究的目的是调查英国生物银行中血压正常且无合并症和既往CV疾病的健康参与者中动脉僵硬(ASI>10米/秒)的决定因素。因此,对22452名健康参与者进行了一项横断面研究。结果:参与者被分为两组,即ASI>10米/秒(n = 5782,25.8%)和ASI<10米/秒(n = 16670,74.2%)。所有显著的单变量协变量都纳入了多变量分析。与AS相关的其余独立因素为年龄(OR = 1.063,阈值 = 53.0岁,p < 0.001)、体重指数(OR = 1.0450,阈值 = 24.9千克/平方米,p < 0.001)、胱抑素c(OR = 1.384,阈值 = 0.85毫克/升,p = 0.011)、磷酸盐(OR = 2.225,阈值 = 1.21毫摩尔/升,p < 0.001)、甘油三酯(OR = 1.281,阈值 = 1.09毫摩尔/升,p < 0.001)、平均血压(OR = 1.028,阈值 = 91.2毫米汞柱,p < 0.001)、心率(OR = 1.007,阈值 = 55次/分钟,p < 0.001)、碱性磷酸酶(OR = 1.002,阈值 = 67.9单位/升,p = 0.004)、白蛋白(OR = 0.973,阈值 = 46.0克/升,p < 0.001)、性别(男性,OR = 1.657,p < 0.001)和吸烟(当前,OR = 1.871,p < 0.001)。结论:AS与多个参数相关,应在未来的前瞻性研究中进行调查。确定健康参与者中ASI升高标志物有助于制定未来CV风险的预防策略。